Wei‐Kung Tseng

1.1k total citations
41 papers, 437 citations indexed

About

Wei‐Kung Tseng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei‐Kung Tseng has authored 41 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei‐Kung Tseng's work include Lipoproteins and Cardiovascular Health (12 papers), Cardiovascular Function and Risk Factors (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Wei‐Kung Tseng is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Cardiovascular Function and Risk Factors (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Wei‐Kung Tseng collaborates with scholars based in Taiwan, Japan and China. Wei‐Kung Tseng's co-authors include Chau‐Chung Wu, Chin‐Feng Hsuan, Chih‐Kun Huang, Kai‐Chien Yang, Wei-Hsian Yin, Hung‐I Yeh, Chi‐Ming Tai, Yen‐Wen Wu, Jaw‐Wen Chen and Huey‐Dong Wu and has published in prestigious journals such as Applied Physics Letters, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Wei‐Kung Tseng

39 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Kung Tseng Taiwan 12 215 175 77 60 50 41 437
Mika Mori Japan 12 307 1.4× 168 1.0× 172 2.2× 56 0.9× 64 1.3× 46 598
Georgios Efstratiadis Greece 13 114 0.5× 178 1.0× 53 0.7× 60 1.0× 69 1.4× 25 500
Naoyasu Maeda Japan 9 130 0.6× 140 0.8× 66 0.9× 37 0.6× 79 1.6× 12 349
Tomoyuki Kunishima Japan 15 346 1.6× 283 1.6× 88 1.1× 63 1.1× 52 1.0× 49 597
Chee Jeong Kim South Korea 12 176 0.8× 124 0.7× 146 1.9× 35 0.6× 28 0.6× 49 380
Jane K. Stock France 9 263 1.2× 92 0.5× 90 1.2× 64 1.1× 16 0.3× 40 436
Zhaoxue Sheng China 11 137 0.6× 197 1.1× 38 0.5× 127 2.1× 31 0.6× 47 413
Jordan M Kraaijenhof Netherlands 8 136 0.6× 99 0.6× 44 0.6× 64 1.1× 22 0.4× 21 323
A. Anderson United States 7 134 0.6× 106 0.6× 75 1.0× 59 1.0× 12 0.2× 17 383

Countries citing papers authored by Wei‐Kung Tseng

Since Specialization
Citations

This map shows the geographic impact of Wei‐Kung Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Kung Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Kung Tseng more than expected).

Fields of papers citing papers by Wei‐Kung Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Kung Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Kung Tseng. The network helps show where Wei‐Kung Tseng may publish in the future.

Co-authorship network of co-authors of Wei‐Kung Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Kung Tseng. A scholar is included among the top collaborators of Wei‐Kung Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Kung Tseng. Wei‐Kung Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Liang‐Yu, Ting‐Ting Chang, Chin‐Chou Huang, et al.. (2024). Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clinical Research in Cardiology. 114(8). 952–968. 4 indexed citations
3.
Huang, Chin‐Chou, Hsin‐Bang Leu, Wei-Hsian Yin, et al.. (2023). Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study. BMC Cardiovascular Disorders. 23(1). 564–564. 4 indexed citations
4.
Hsuan, Chin‐Feng, Wei‐Kung Tseng, Chau‐Chung Wu, et al.. (2021). Glossogyne tenuifolia Extract Increases Nitric Oxide Production in Human Umbilical Vein Endothelial Cells. Pharmaceuticals. 14(6). 577–577. 3 indexed citations
5.
Li, Yi‐Heng, Wei‐Kung Tseng, Wei-Hsian Yin, et al.. (2020). Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment. Scientific Reports. 10(1). 21835–21835. 5 indexed citations
6.
Yin, Wei‐Hsian, Pei‐Jer Chen, Hung‐I Yeh, et al.. (2016). Combination With Low-dose Dextromethorphan Improves the Effect of Amlodipine Monotherapy in Clinical Hypertension. Medicine. 95(12). e3234–e3234. 3 indexed citations
7.
Wang, Jia-Jung, et al.. (2016). A vibration-based approach to quantifying the dynamic elastance of the superficial arterial wall. BioMedical Engineering OnLine. 15(1). 40–40. 3 indexed citations
8.
9.
Ho, Li‐Ting, Wei-Hsian Yin, Shao‐Yuan Chuang, et al.. (2015). Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan. PLoS ONE. 10(3). e0116513–e0116513. 31 indexed citations
10.
Lin, Tsung‐Hsien, Shao‐Yuan Chuang, Chun‐Yuan Chu, et al.. (2014). The Impact of Chronic Kidney Disease on Lipid Management and Goal Attainment in Patients with Atherosclerosis Diseases in Taiwan. International Journal of Medical Sciences. 11(4). 381–388. 11 indexed citations
11.
Jeng, Jiann‐Shing, Wei-Hsian Yin, Chin‐Chou Huang, et al.. (2013). Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan. Journal of the Formosan Medical Association. 114(10). 1000–1007. 13 indexed citations
12.
13.
Wei, Yu-Feng, Wei‐Kung Tseng, Chih‐Kun Huang, et al.. (2011). Surgically induced weight loss, including reduction in waist circumference, is associated with improved pulmonary function in obese patients. Surgery for Obesity and Related Diseases. 7(5). 599–604. 25 indexed citations
14.
Hsuan, Chin‐Feng, Chih‐Kun Huang, Jou‐Wei Lin, et al.. (2010). The Effect of Surgical Weight Reduction on Left Ventricular Structure and Function in Severe Obesity. Obesity. 18(6). 1188–1193. 51 indexed citations
15.
Hsuan, Chin‐Feng, et al.. (2010). Detachment of Composite Graft After Bentall's Operation Manifested as Acute Myocardial Infarction. Journal of the American College of Cardiology. 55(2). e3–e3. 2 indexed citations
16.
Hsuan, Chin‐Feng, et al.. (2009). A Retrospective Study of Statin Use and Its Effectiveness in Taiwanese. Zhōnghuá mínguó xīnzàngxué huì zázhì. 25(1). 18–25. 10 indexed citations
17.
Wu, Chau‐Chung, Shu‐Huei Wang, Wei‐Kung Tseng, et al.. (2009). OxLDL upregulates caveolin‐1 expression in macrophages: Role for caveolin‐1 in the adhesion of oxLDL‐treated macrophages to endothelium. Journal of Cellular Biochemistry. 107(3). 460–472. 30 indexed citations
18.
Wei, Yu‐Feng, Huey‐Dong Wu, Chi‐Yang Chang, et al.. (2009). The Impact of Various Anthropometric Measurements of Obesity on Pulmonary Function in Candidates for Surgery. Obesity Surgery. 20(5). 589–594. 25 indexed citations
19.
Hsuan, Chin‐Feng, et al.. (2008). Is it Cost-Effective to Change Brand-Name to Generic Simvastatin in Taiwan?. Zhōnghuá mínguó xīnzàngxué huì zázhì. 24(4). 191–197. 1 indexed citations
20.
Yang, Kai‐Chien, Jung‐Yien Chien, Wei‐Kung Tseng, et al.. (2007). Statins do not improve short-term survival in an oriental population with sepsis. The American Journal of Emergency Medicine. 25(5). 494–501. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mika Mori Breakdown of academic impact, for papers by Georgios Efstratiadis Breakdown of academic impact, for papers by Naoyasu Maeda Breakdown of academic impact, for papers by Tomoyuki Kunishima Breakdown of academic impact, for papers by Chee Jeong Kim Breakdown of academic impact, for papers by Jane K. Stock Breakdown of academic impact, for papers by Zhaoxue Sheng Breakdown of academic impact, for papers by Jordan M Kraaijenhof Breakdown of academic impact, for papers by A. Anderson
Rankless by CCL
2026